1. Bisson, J.I., et al., Post-traumatic stress disorder. BMJ, 2015. 351: p. h6161.
2. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders,5th edn. American Psychiatric Publishing,Arlington,VA, 2013.
3. Edmondson, D., et al., Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am Heart J, 2013. 166(5): p. 806-14.
4. Afari, N., et al., Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med, 2014. 76(1): p. 2-11.
5. Mellon, S.H., et al., Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder. Biological psychiatry, 2018. 83(10): p. 866-875.
6. Shalev, A., I. Liberzon, and C. Marmar, Post-Traumatic Stress Disorder. N Engl J Med, 2017. 376(25): p. 2459-2469.
7. Zass, L.J., et al., Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity. Psychiatr Genet, 2017. 27(1): p. 1-16.
8. Sumner, J.A., et al., Posttraumatic Stress Disorder and Inflammation: Untangling Issues of Bidirectionality. Biol Psychiatry, 2020. 87(10): p. 885-897.
9. Pearson-Leary, J., et al., The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats. Mol Psychiatry, 2020. 25(5): p. 1068-1079.
10. Ha, M. and V.N. Kim, Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol, 2014. 15(8): p. 509-24.
11. Bi, Y., G. Liu, and R. Yang, MicroRNAs: novel regulators during the immune response. J Cell Physiol, 2009. 218(3): p. 467-72.
12. Hatfield, S. and H. Ruohola-Baker, microRNA and stem cell function. Cell Tissue Res, 2008. 331(1): p. 57-66.
13. Gauthier, B.R. and C.B. Wollheim, MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med, 2006. 12(1): p. 36-8.
14. Xu, J., et al., miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases. Cell Mol Neurobiol, 2021.
15. Alsharafi, Walid A., et al., MicroRNA in glutamate receptor-dependent neurological diseases. Clinical Science, 2017. 131(14): p. 1591-1604.
16. Bredy, T.W., et al., MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem, 2011. 96(1): p. 89-94.
17. Saraiva, C., M. Esteves, and L. Bernardino, MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases. Biochem Pharmacol, 2017. 141: p. 118-131.
18. Manakov, S.A., et al., A Neuronal Transcriptome Response Involving Stress Pathways is Buffered by Neuronal microRNAs. Front Neurosci, 2012. 6: p. 156.
19. Cardoso, A.L., J.R. Guedes, and M.C. de Lima, Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions. Curr Opin Pharmacol, 2016. 26: p. 1-9.
20. Ponomarev, E.D., et al., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med, 2011. 17(1): p. 64-70.
21. O'Connell, R.M., D.S. Rao, and D. Baltimore, microRNA regulation of inflammatory responses. Annu Rev Immunol, 2012. 30: p. 295-312.
22. Li, Y. and X. Shi, MicroRNAs in the regulation of TLR and RIG-I pathways. Cell Mol Immunol, 2013. 10(1): p. 65-71.
23. Lopez-Ramirez, M.A. and S. Nicoli, Role of miRNAs and epigenetics in neural stem cell fate determination. Epigenetics, 2014. 9(1): p. 90-100.
24. Mishima, T., et al., RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS. Brain Res, 2007. 1131(1): p. 37-43.
25. Angelopoulou, E., Y.N. Paudel, and C. Piperi, miR-124 and Parkinson's disease: A biomarker with therapeutic potential. Pharmacol Res, 2019. 150: p. 104515.
26. Soreq, H. and Y. Wolf, NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol Med, 2011. 17(10): p. 548-55.
27. Smith, P., et al., In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem, 2011. 116(2): p. 240-7.
28. Han, D., et al., MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders. Front Pharmacol, 2019. 10: p. 1555.
29. Wan, Y., et al., Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology, 2007. 106(3): p. 436-43.
30. Chen, Y., et al., miR-124/VAMP3 is a novel therapeutic target for mitigation of surgical trauma-induced microglial activation. Signal Transduct Target Ther, 2019. 4: p. 27.
31. Chivero, E.T., et al., Engineered Extracellular Vesicles Loaded With miR-124 Attenuate Cocaine-Mediated Activation of Microglia. Front Cell Dev Biol, 2020. 8: p. 573.
32. Nie, P.Y., et al., miR-142 downregulation alleviates rat PTSD-like behaviors, reduces the level of inflammatory cytokine expression and apoptosis in hippocampus, and upregulates the expression of fragile X mental retardation protein. J Neuroinflammation, 2021. 18(1): p. 17.
33. Walsh, M.C., J. Lee, and Y. Choi, Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev, 2015. 266(1): p. 72-92.
34. Dou, Y., et al., Roles of TRAF6 in Central Nervous System. Curr Neuropharmacol, 2018. 16(9): p. 1306-1313.
35. Jakus, P.B., et al., TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. J Nutr Biochem, 2013. 24(5): p. 819-23.
36. Chandel, N.S., P.T. Schumacker, and R.H. Arch, Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem, 2001. 276(46): p. 42728-36.
37. Li, T., et al., The Ubiquitin E3 Ligase TRAF6 Exacerbates Ischemic Stroke by Ubiquitinating and Activating Rac1. J Neurosci, 2017. 37(50): p. 12123-12140.
38. Nataf, S., M. Guillen, and L. Pays, Common Neurodegeneration-Associated Proteins Are Physiologically Expressed by Human B Lymphocytes and Are Interconnected via the Inflammation/Autophagy-Related Proteins TRAF6 and SQSTM1. Front Immunol, 2019. 10: p. 2704.
39. Feng, H., et al., EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest, 2014. 124(9): p. 3741-56.
40. Liberzon, I., M. Krstov, and E.A. Young, Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology, 1997. 22(6): p. 443-53.
41. Shi, J.H. and S.C. Sun, Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways. Front Immunol, 2018. 9: p. 1849.
42. Kapoor, M., et al., Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain. Biomed Pharmacother, 2018. 97: p. 458-472.
43. Vincent, S.R. and B.T. Hope, Neurons that say NO. Trends Neurosci, 1992. 15(3): p. 108-13.
44. Contestabile, A. and E. Ciani, Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem Int, 2004. 45(6): p. 903-14.
45. Cossenza, M., et al., Nitric oxide in the nervous system: biochemical, developmental, and neurobiological aspects. Vitam Horm, 2014. 96: p. 79-125.
46. Ehrlich, I., et al., PSD-95 is required for activity-driven synapse stabilization. Proc Natl Acad Sci U S A, 2007. 104(10): p. 4176-81.
47. Cesca, F., et al., The synapsins: key actors of synapse function and plasticity. Prog Neurobiol, 2010. 91(4): p. 313-48.
48. Lynch, M.A., Long-term potentiation and memory. Physiol Rev, 2004. 84(1): p. 87-136.
49. Zhu, Y., et al., Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures. Int J Mol Sci, 2015. 17(1).
50. Dutta, G., P. Zhang, and B. Liu, The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol, 2008. 22(5): p. 453-64.
51. Sharon, G., et al., The Central Nervous System and the Gut Microbiome. Cell, 2016. 167(4): p. 915-932.
52. Thion, M.S., et al., Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner. Cell, 2018. 172(3): p. 500-516.e16.
53. Benakis, C., et al., The microbiome-gut-brain axis in acute and chronic brain diseases. Curr Opin Neurobiol, 2020. 61: p. 1-9.
54. Veremeyko, T., et al., IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation. PLoS One, 2013. 8(12): p. e81774.
55. Song, Y., et al., M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics, 2019. 9(10): p. 2910-2923.
56. Fischbach, S.J. and T.J. Carew, MicroRNAs in memory processing. Neuron, 2009. 63(6): p. 714-6.
57. Aalaei-Andabili, S.H. and N. Rezaei, MicroRNAs (MiRs) Precisely Regulate Immune System Development and Function in Immunosenescence Process. Int Rev Immunol, 2016. 35(1): p. 57-66.
58. Wang, X., et al., A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease. Biol Psychiatry, 2018. 83(5): p. 395-405.
59. Zhou, Y., et al., Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease. J Alzheimers Dis, 2019. 67(2): p. 571-581.
60. Dong, R.F., et al., The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5. J Cell Biochem, 2018. 119(1): p. 269-277.
61. Yao, L., et al., MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease. J Neuroinflammation, 2018. 15(1): p. 13.
62. Lee, S.T., et al., Exosome-Based Delivery of miR-124 in a Huntington's Disease Model. J Mov Disord, 2017. 10(1): p. 45-52.
63. Johnson, R. and N.J. Buckley, Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromolecular Med, 2009. 11(3): p. 183-99.
64. Deo, M., et al., Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn, 2006. 235(9): p. 2538-48.
65. Krichevsky, A.M., et al., Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells, 2006. 24(4): p. 857-64.
66. Periyasamy, P., et al., Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling. Mol Neurobiol, 2018. 55(4): p. 3196-3210.
67. Yang, Y., et al., Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-κB pathway after intracerebral hemorrhage. Biomed Pharmacother, 2020. 126: p. 110044.
68. Ma, Q., et al., Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity. Proc Natl Acad Sci U S A, 2017. 114(41): p. E8760-E8769.
69. Vemula, S.K., et al., The Interaction of TRAF6 With Neuroplastin Promotes Spinogenesis During Early Neuronal Development. Front Cell Dev Biol, 2020. 8: p. 579513.
70. Dilshara, M.G., et al., Downregulation of NO and PGE2 in LPS-stimulated BV2 microglial cells by trans-isoferulic acid via suppression of PI3K/Akt-dependent NF-κB and activation of Nrf2-mediated HO-1. Int Immunopharmacol, 2014. 18(1): p. 203-11.
71. Park, H.Y., et al., Purpurogallin exerts anti‑inflammatory effects in lipopolysaccharide‑stimulated BV2 microglial cells through the inactivation of the NF‑κB and MAPK signaling pathways. Int J Mol Med, 2013. 32(5): p. 1171-8.
72. Song, F., et al., Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling Pathways. PLoS One, 2016. 11(2): p. e0149991.
73. Stellwagen, D. and R.C. Malenka, Synaptic scaling mediated by glial TNF-alpha. Nature, 2006. 440(7087): p. 1054-9.
74. Bezzi, P., et al., CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci, 2001. 4(7): p. 702-10.
75. González-Burgos, I., From synaptic transmission to cognition: an intermediary role for dendritic spines. Brain Cogn, 2012. 80(1): p. 177-83.
76. González-Ramírez, M.M., et al., Changes in the plastic properties of hippocampal dendritic spines underlie the attenuation of place learning in healthy aged rats. Neurobiol Learn Mem, 2014. 109: p. 94-103.
77. Cingolani, L.A. and Y. Goda, Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci, 2008. 9(5): p. 344-56.